Events

Horizon Europe Belgian launch event
NOV
Thu
12
13:15 - 15:05

This was 5 years ago

Location

Webinar


Programmes
Horizon 2020

The start of Horizon Europe, the new EU Framework Programme for Research and Innovation, is approaching.

The Director-General of the Directorate “Research and Innovation” of the European Commission, Mr. Jean-Eric Paquet, will present all the novelties of the programme and answer your questions.

This will be followed by interviews with 2 beneficiaries of the Horizon 2020 programme.

And you will be also informed about the Belgian concertation groups, reponsible for preparing the position of the Belgian delegation in committees of the EU Framework Programme, and the NCP organisations in Belgium.

Participation is free but registration is mandatory, which will close on November 12 at 9 am.

Registration and full agenda can be found here

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.